An Overview of Recombinant DNA Technology

An Overview of Recombinant DNA TECHNOLOGY

Recombinant DNA (rDNA) technology, also known as genetic engineering, represents a revolutionary branch of biotechnology that enables the direct manipulation and alteration of the genetic material (DNA) of an organism. This technology involves combining DNA molecules from different sources to create new genetic combinations that are valuable for scientific research, medicine, agriculture, and industry. The foundation of rDNA technology lies in the understanding that DNA is the principal molecule responsible for the expression and inheritance of characters in living organisms. Scientists realized that by manipulating nucleic acids, it is possible to alter the genetic makeup of organisms to achieve desired traits or produce valuable products. The development of rDNA technology is a culmination of advances in various biological disciplines including biochemistry, genetics, molecular biology, cytology, and microbiology. Key milestones include the isolation and purification of nucleic acids, elucidation of the chemical and physical structure of DNA (notably the double helix model proposed by Watson and Crick), and understanding the processes of DNA replication, transcription, and translation. These discoveries provided the conceptual framework for manipulating DNA molecules. A critical breakthrough was the discovery of enzymes that can cut and join DNA molecules precisely. Restriction enzymes (or restriction endonucleases), discovered by Werner Arber, Hamilton Smith, and Daniel Nathans, act as molecular scissors that cut DNA at specific sequences. DNA ligase, discovered by Gellert, Lehman, Richardson, and Hurwitz, is an enzyme that joins DNA fragments together. These tools enabled scientists to cut DNA from one organism and insert it into another, creating recombinant DNA molecules. Another important observation was that bacteria can naturally take up foreign DNA fragments from their environment and integrate them into their genome, a process known as transformation. Stanley Cohen and Herbert Boyer combined their expertise to develop the first recombinant DNA molecules by cutting plasmid DNA from one bacterial species and inserting DNA from another species, then introducing these recombinant plasmids into Escherichia coli for replication and cloning. This marked the beginning of modern genetic engineering. The applications of rDNA technology have been transformative. For instance, human insulin and growth hormone, previously extracted in limited quantities from animal sources, can now be produced in large quantities using genetically engineered bacteria, reducing cost and immunogenic reactions. Similarly, therapeutic proteins like interferons and enzymes like plasminogen activator are produced through rDNA technology. In agriculture, genetically modified crops have been developed with traits such as disease resistance, drought tolerance, and improved nutritional quality, enhancing crop yield and farmer income. The chapter also highlights the historical timeline of key discoveries and innovations that paved the way for rDNA technology, emphasizing its interdisciplinary nature and the collaborative efforts of scientists worldwide. The future of biotechnology envisions producing important therapeutic proteins and vaccines from plants, which would be cost-effective and safer compared to animal-based products. In summary, recombinant DNA technology is a powerful tool that enables the isolation, manipulation, and propagation of desired genes, facilitating their study and application in various fields to improve human health, agriculture, and industry.

• Recombinant DNA technology involves combining DNA from different sources to create new genetic combinations.
• It is based on discoveries in molecular biology, genetics, biochemistry, and microbiology.
• Restriction enzymes cut DNA at specific sites; DNA ligase joins DNA fragments.
• Bacteria can naturally take up foreign DNA, enabling gene cloning.
• Applications include production of human insulin, growth hormone, disease-resistant crops, and therapeutic proteins.
• The technology has revolutionized medicine, agriculture, and research.
• 📌 Recombinant DNA (rDNA): DNA molecules formed by combining genetic material from different sources.
• 📌 Restriction enzymes: Enzymes that cut DNA at specific sequences.
• 📌 DNA ligase: Enzyme that joins DNA fragments together.

Historical Development of Recombinant DNA Technology

The historical development of recombinant DNA technology spans over a century, marked by key discoveries that laid the foundation for modern biotechnology. The timeline begins in 1917 when Karl Ereky coined the term 'Biotechnology', referring to the use of biological processes for industrial and other practical purposes. In 1944, Avery, MacLeod, and McCarty demonstrated that DNA is the genetic material responsible for heredity, shifting scientific focus to nucleic acids. The discovery of plasmids by Joshua Lederberg in 1952 revealed extra-chromosomal DNA elements in bacteria capable of autonomous replication, which later became crucial vectors in gene cloning. The double helical structure of DNA proposed by Watson and Crick in 1953 provided insight into DNA replication and gene expression mechanisms. During the 1960s, Werner Arber and Matthew Meselson discovered Type I restriction enzymes, followed by the discovery of DNA ligase enzymes by Gellert, Lehman, Richardson, and Hurwitz in 1967. These enzymes became essential tools for cutting and joining DNA fragments. In 1970, Hamilton O. Smith and Thomas J. Kelly discovered Type II restriction enzymes, which cut DNA at specific sites, enabling precise genetic manipulation. Paul Berg assembled the first recombinant DNA molecule in 1972 by combining DNA from a bacterium and a virus. The landmark development of DNA cloning and recombinant DNA technology was achieved in 1973 by Stanley N. Cohen and Herbert Boyer, who successfully combined DNA from different bacterial species into plasmids and propagated them in Escherichia coli. This breakthrough led to the creation of genetically modified organisms. Further advancements include the description of Hybridoma technology by Georges J.F. Köhler and César Milstein in 1975 for producing monoclonal antibodies, the approval of the first recombinant DNA therapeutic product 'Humulin' in 1982, and the invention of the Polymerase Chain Reaction (PCR) by Kary Mullis in 1983, which revolutionized DNA amplification. Other milestones include the invention of DNA fingerprinting by Sir Alec Jeffreys in 1984, development of recombinant vaccines such as Recombivax HB for Hepatitis B in 1986, initiation and completion of the Human Genome Project (1990-2003), and the development of genetically engineered crops like Flavr Savr tomato (1994) and Bt cotton (1996). Recent achievements include the discovery of RNA interference (gene silencing) in 2006, cloning of the first mammal Dolly the sheep in 1996, development of Golden Rice in 2000, and the Nobel prize-winning discovery of the CRISPR-Cas9 genome editing tool in 2019. The rapid development of recombinant vaccines against COVID-19 and the awarding of the Nobel prize for mRNA vaccine technology in 2023 highlight the ongoing impact of rDNA technology. This timeline underscores the interdisciplinary nature of biotechnology and the cumulative contributions of scientists worldwide that have shaped the field. **Table on page 6 (17×2)** | 1917 | Karl Ereky coined the term ‘Biotechnology’ | | --- | --- | | 1944 | Avery, MacLeod and McCarty demonstrated that ‘DNA is the genetic material’ | | 1952 | Joshua Lederberg discovered ‘Plasmids’ | | 1953 | Watson and Crick proposed ‘Double Helical structure of DNA’ | | 1960s | Werner Arber, Matthew Meselson discovered ‘Type I restriction enzymes’ | | 1967 | Gellert, Lehman, Richardson and Hurwitz discovered ‘ligase enzymes’ | | 1970 | Hamilton O. Smith and Thomas J. Kelly discovered ‘Type II restriction enzymes’ | | 1972 | Paul Berg assembled the first ‘Recombinant DNA’ from a bacterium into the virus | | 1973 | Stanley N. Cohen and Herbert Boyer developed ‘DNA cloning and rDNA technology’ | | 1975 | Georges J.F. Köhler and César Milstein described the ‘Hybridoma Technology’ for production of monoclonal antibodies | | 1982 | FDA approved world’s first recombinant DNA Therapeutic Product ‘Humulin’ developed by Eli Lilly and Genentech | | 1983 | Kary Mullis developed ‘Polymerase Chain Reaction’ | | 1984 | Sir Alec Jeffreys invented ‘DNA Fingerprinting’ | | 1986 | The first recombinant vaccine ‘Recombivax HB’ for Hepatitis B was approved for human use | | 1990 | ‘Human Genome Project’ officially initiated which was coordinated by the U.S. Department of Energy (DOE) and the National Institutes of Health (NIH) | | 1994 | The first genetically engineered crop ‘Flavr Savr’ tomato was introduced that was produced by Calgene in 1992 | | 1996 | Keith Campbell and Ian Wilmut cloned the first mammal ‘Dolly’ the sheep from somatic cell using nuclear transfer technique. | **Table on page 7 (11×2)** | 1996 | Researchers at Monsanto developed ‘Bt cotton’ and first commercially released it in China and the United States in 1996, followed by its introduction in India in 2003 | | --- | --- | | 2000 | Ingo Potrykus and Peter Beyer developed ‘Golden Rice’ | | 2003 | The Human Genome Project (HGP) was completed | | 2004 | ‘Avastin’, an anti-VEGF monoclonal antibody for cancer treatment was developed | | 2006 | A recombinant vaccine ‘Gardasil’ against human papillomavirus (HPV) received FDA approval | | 2006 | Nobel prize awarded for discovery of RNA interference ‘Gene Silencing’ by double stranded RNA | | 2010 | Robert Edwards awarded Nobel Prize for the development of human ‘in vitro fertilization’ (IVF) therapy | | 2012 | Shinya Yamanaka and John B. Gurdon discovered that mature differentiated cells can be reprogrammed into ‘Induced Pluripotent Stem Cells’ | | 2019 | Nobel prize awarded for discovery of ‘CRISPR-Cas9’ genome editing tool | | 2020 | Recombinant vaccines against COVID-19 was developed. | | 2023 | Nobel prize awarded for the mRNA vaccine against covid-19 |

• 1917: Karl Ereky coined 'Biotechnology'.
• 1944: DNA identified as genetic material by Avery, MacLeod, and McCarty.
• 1952: Discovery of plasmids by Joshua Lederberg.
• 1953: Double helix structure of DNA proposed by Watson and Crick.
• 1960s-70s: Discovery of restriction enzymes and DNA ligase.
• 1973: Cohen and Boyer developed recombinant DNA technology.
• 1982: First recombinant therapeutic product 'Humulin' approved.
• 1990-2003: Human Genome Project completed.
• 1996: Cloning of Dolly the sheep.
• 2019: Discovery of CRISPR-Cas9 genome editing tool.